WCLC 2025 - Posters & ePosters-P1.11.72 Phase II Study of Combination Azacitidine and Entinostat and Nivolumab in Patients With Metastatic Non-Small Cell Lung Cancer

P1.11.72 Phase II Study of Combination Azacitidine and Entinostat and Nivolumab in Patients With Metastatic Non-Small Cell Lung Cancer

Asset Subtitle

Kristen Marrone

Meta Tag

Speaker Kristen Marrone

Topic Metastatic Non-small Cell Lung Cancer – Immunotherapy